Drug Eye Africa

AMMPS recalls one batch of Vinrab rabies immunoglobulin over non-conformity

The Agence Marocaine du Médicament et des Produits de Santé (AMMPS) has ordered a batch recall of Vinrab 1000 UI/5 ml, solution injectable.

The affected batch is 08AR26004. The product is the responsibility of the pharmaceutical establishment MARBIO. The alert was issued on 15 October 2026.

The authority detected a “non-conformity” concerning batch 08AR26004. The notice does not specify the nature of the non-conformity.

Stockholders must immediately cease distribution and use of the batch, quarantine remaining stock, and return the batch to MARBIO according to the recall procedures. Other conforming batches of this product remain available to ensure supply continuity.

Vinrab is a rabies immunoglobulin at a concentration of 1000 UI/5 ml, formulated as an injectable solution.

Sources

About the author

Drug Eye Africa Newsroom

Drug Eye Africa Newsroom

The Drug Eye Africa newsroom reports on medicines regulation, recalls and medicine quality across the African continent. Alerts are matched against the issuing authority's published notice before publication, and corrections are timestamped on the article rather than made silently.

Regulatory alerts and news, direct to your inbox

Independent pharmaceutical news and regulatory intelligence covering Africa.

Scroll to Top